Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy
PLoS One
.
2016 Jul 8;11(7):e0159286.
doi: 10.1371/journal.pone.0159286.
eCollection 2016.
Authors
Josep M Llibre
,
François Raffi
,
Graeme Moyle
,
Georg Behrens
,
Stephane Bouee
,
Geraldine Reilly
,
Peter Borg
,
David Piontkowsky
,
Felipe Rogatto
PMID:
27391807
PMCID:
PMC4938098
DOI:
10.1371/journal.pone.0159286
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0155406.].
Publication types
Published Erratum